SCHEMBL22331682

SCHEMBL22331682

O=C(O)c1cn(-c2c(F)cc(F)cc2Cl)c2nc(N3CC(O)CC3=O)ccc2c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHA2 P29317 1/20 0.41
FLT4 P35916 1/20 0.41
GSK3B P49841 1/20 0.41
RARB P10826 1/20 0.41
TBXAS1 P24557 1/20 0.41
SLC6A3 Q01959 1/20 0.41
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 3/20 0.38
LMNA P02545 3/20 0.38
KDM4E B2RXH2 2/20 0.38
POLB P06746 2/20 0.38
HPGD P15428 1/20 0.38
XBP1 P17861 1/20 0.38
NFKB1 P19838 1/20 0.38
HTT P42858 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18306063 1.00 EPHA2 (0.41) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL18312917 0.94 EPHA2 (0.43) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL22331792 0.94 EPHA2 (0.43) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL22591811 0.92 EPHA2 (0.35) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL22331732 0.92 EPHA2 (0.35) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL18306064 0.90 EPHA2 (0.31) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL22331787 0.88 CAPN1 (0.35) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL18313225 0.87 CNR2 (0.36)
SCHEMBL22331788 0.87 CNR2 (0.36)
SCHEMBL22331789 0.86 ALDH1A1 (0.38) EPHA2FLT4GSK3BKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3307741-B1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARIC M2 RECEPTOR Bayer Pharma AG (DE) 2020-10-28 EP disclosed
EP-3692991-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC M2 RECEPTOR Bayer Pharma Aktiengesellschaft (DE) 2020-08-12 EP disclosed